TABLE 3.

Clinical recovery variables and complications.

Variables	Remimazolam group (n = 28)	Propofol group (n = 28)	P-value
Emergence time, min	4 [3, 11.8]	15 [12.0, 19.8]	0.001**
Time to extubate, min	5 [3.0, 13.8]	15 [12.3, 20.0]	0.001**
Recovery time, min	5 [3.3, 12.5]	15 [13.3, 20.8]	0.000**
Post-operative hospital stays (d)	2 [1, 3]	2 [1, 3]	0.800
Injection site pain, n (%)	0 (0)	6 (21.4)	0.030*
Intraoperative atropine use, n (%)	0 (0)	3 (10.7)	0.236
Blood lactate at the end of surgery (mmol/L)	0.81 ± 0.21	0.89 ± 0.36	0.388
Blood glucose at the end of surgery (mmol/L)	6.79 ± 1.38	6.01 ± 0.73	0.030*

Data are presented as mean ± SD, median [quartile 1, quartile 3] or n (percentages). Denotes statistically significant (*p < 0.05 or **p < 0.01) differences among the two groups. Emergence time was defined as the time from discontinuation of remimazolam or propofol to MOAA/S = 5 measured repetitively three times; Recovery time was defined as the time from discontinuation of remimazolam or propofol to modified Aldrete score returned to 9.